课题基金 / 基金详情

AI Risk Management Platform for Insurance Industry

AI Risk Management Platform for Insurance Industry
保险行业人工智能风险管理平台
批准号:
10067619
负责人:
金额:
$6.33万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
已结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
Holistic AI(HAI)将领导一个联盟,开发首个面向市场的保险AI风险管理平台。该平台是与我们的保险公司和人工智能技术合作伙伴共同构思的,使保险公司能够评估人工智能风险并为保险定价;并允许人工智能公司通过风险管理工具和获得有效的保险来管理和减轻人工智能开发和部署风险。该联盟将帮助塑造快速崛起的政策和监管格局,以实现可信和负责任的AI/ML。该联盟汇集了HAI在AI,数据和软件开发以及风险保证专业知识方面的深厚专业知识; UCL的学术和政策专业知识;以及包括保险提供商在内的最终用户利益相关者。对HAI平台的需求是由AI和ML在社会中的快速采用推动的。它已经广泛应用于金融和银行、汽车(自动驾驶汽车)、医药和医疗保健(机器人手术、临床试验、自动图像诊断等)等领域,并越来越多地用于人力资源和法律的决策。随着这一增长和日益复杂的用例,人们越来越关注与人工智能相关的风险,地球仪迅速出现的立法和法规正在极大地改变格局,并反映(和放置)使用人工智能的公司必须防范的风险。HAI将领导一个联盟,以满足全球对人工智能,机器学习和算法问题的保险需求。这些可能是灾难性的-Knight Capital因算法交易系统问题而破产的4.5亿美元就是明证。该联盟面临的主要挑战是定义哪些风险应该优先考虑和衡量,并创建实现这一目标的工具。HAI已经为AI审计和保证提供了一套复杂的系统,该系统将算法流程分解为多个垂直领域,同时考虑用例和用户/运营商风险和监督。HAI目前与联合利华等企业合作,评估其多个AI项目的偏见和失败,为新兴监管环境中的跨国应用做好准备。新的风险管理平台将专注于特定的保险行业要求,评估和量化AI,ML和算法应用中的潜在风险。利用我们现有的评估能力和更广泛的要求,它创建了一个定价和评估结构,使算法保险。这创造了一个独特的产品,提供了第一个适合保险公司AI评估的工具,使英国处于数十亿美元市场的中心。
英文摘要
Holistic AI (HAI) will lead a consortium in the development of the first-to-market AI Risk Management Platform for insurance. The Platform has been co-conceived with our insurer and AI technology partners to enable insurers to evaluate AI risk and to price insurance; and to allow AI companies to manage and mitigate AI development and deployment risks via risk management tools and by accessing effective insurance. The consortium will help shape the rapidly emerging policy and regulatory landscape for trusted and responsible AI/ML.The consortium brings together HAI's deep expertise in AI, data and software development and risk assurance knowhow; academic and policy expertise at UCL; and end user stakeholders including insurance providers.The need for the HAI platform is driven by the rapid adoption of AI and ML across society. It is already widely used in sectors spanning finance and banking, automotive (autonomous vehicles), medicine and healthcare (robotic surgery, clinical trials, automated image diagnosis, etc.), and is increasingly being used in HR and legal decisions. With this growth and with increasingly complex use cases, there is increasing concern about the risks associated with AI, with legislation and regulations emerging rapidly across the globe, which are dramatically changing the landscape, and reflect (and place) risks upon companies utilising AI which they must protect against.HAI will lead a consortium to meet global needs of insuring against AI, ML and algorithmic issues. These can be catastrophic - evidenced by KnIght Capital's $450m bankruptcy due to algorithmic trading system issues. Key challenges for the consortium are to define which risks should be prioritised and measured, and to create the tools to enable this.HAI already provides a sophisticated suite of systems for AI audit and assurance, which break down algorithmic processes across multiple verticals, while considering use cases and user/operator risk and oversight. HAI currently works with enterprise companies like Unilever, evaluating their multiple AI projects for bias and failure, ready for multinational application in the emerging regulatory landscape.The new Risk Management Platform will focus on specific insurance Industry requirements, evaluating and quantifying potential risk within/from AI, ML and algorithmic applications. Leveraging our existing assessment capabilities with wider requirements it creates a pricing and assessment structure enabling the insurance of algorithms.This creates a distinct offering providing the first tools suitable for Insurer AI assessment, positioning the UK at the centre of a multi-billion dollar market
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
  • 批准号:
    81973152
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2019
  • 负责人:
    胡东生
  • 依托单位:
基于时间序列间分位相依性(quantile dependence)的风险值(Value-at-Risk)预测模型研究
  • 批准号:
    71903144
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2019
  • 负责人:
    张申
  • 依托单位:
RISK通路在胃泌素介导的心脏缺血再灌注损伤保护中的作用研究
  • 批准号:
    81800239
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    符金娟
  • 依托单位: